Dako Denmark A/S

Dako is a global leader in tissue-based cancer diagnostics. Hospital and research laboratories worldwide use Dako's know-how, reagents, instruments and software to make precise diagnoses and determine the most effective treatment for patients suffering from cancer. Employing more than 1000 people and operating in more than 70 countries, Dako covers essentially all of the global anatomic pathology markets. Dako is owned by the private equity fund EQT.

Headquartered in Denmark and operating in more than 70 locations, Dako's focus is to become first choice for pathologists around the globe.

Mission

We connect to fight cancer!

Vision

To be first choice for pathology laboratories around the globe who strive to deliver the highest standards for speed and accuracy in cancer diagnosis.

For more information please go to: www.dako.com